Finally, we demonstrate that stimulation of the TLR4 pathway in vitro can increase the sensitivity of tumor cells to the chemotherapy agent docetaxel, thus identifying a possible approach to increase the efficacy of this drug in docetaxel-resistant disease. This evidence concerns the gene TLR4 and neoplasm.